Medicare AdvantageCoverageMedium impact
MA11.052f, Ablation of Lung Tumors
Independence Blue Cross·Oncology, Pulmonology, Radiation Oncology·Medical Policy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Policy MA11.052f regarding ablation of lung tumors has been updated effective January 1, 2026. This is a recent Medicare Advantage policy update that may affect coverage, prior authorization requirements, or billing guidelines for lung tumor ablation procedures. The billing team must review the full policy details to identify specific code changes, authorization requirements, or documentation needs.
Action Required
By December 31, 2025: Billing team must obtain and review the complete policy text for MA11.052f from the provided URL to identify: (1) specific CPT/HCPCS codes affected, (2) prior authorization requirements, (3) coverage limitations, and (4) documentation requirements. Update billing system rules, encounter forms, and staff training accordingly. Communicate any changes to providers performing lung ablation procedures. Failure to implement required changes may result in claim denials for Medicare Advantage beneficiaries effective January 1, 2026.